Skip to content
10-Q

Quarterly Report

Galera Therapeutics, Inc. GRTX

0000950170-25-107616

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 75.46M sh
Shares Diluted Q2 2025 · Jun 30, 2025 98.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 98.5M sh
Shares Diluted Q2 2025 · Jun 30, 2024 54.39M sh
Shares Diluted Q2 2025 · Jun 30, 2024 54.39M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$3.69M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$7.51M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $5.23M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $8.29M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$147.95M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$147.23M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$148.04M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$138.03M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$134.69M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$131.19M
Current Liabilities Q2 2025 · Jun 30, 2025 $347K
Current Liabilities Q2 2025 · Dec 31, 2024 $1.67M
Total Liabilities Q2 2025 · Jun 30, 2025 $151.4M
Total Liabilities Q2 2025 · Dec 31, 2024 $153.77M
Current Assets Q2 2025 · Jun 30, 2025 $5.95M
Current Assets Q2 2025 · Dec 31, 2024 $10M
Total Assets Q2 2025 · Jun 30, 2025 $6.05M
Total Assets Q2 2025 · Dec 31, 2024 $10.1M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.07
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.16
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 −$0.07
Eps Basic Q2 2025 · Jun 30, 2024 −$0.16
Sga Expense Q2 2025 · Jun 30, 2025 $1.05M
Sga Expense Q2 2025 · Jun 30, 2025 $2.92M
Sga Expense Q2 2025 · Jun 30, 2024 $2.78M
Sga Expense Q2 2025 · Jun 30, 2024 $5.87M
Rd Expense Q2 2025 · Jun 30, 2025 $84K
Rd Expense Q2 2025 · Jun 30, 2025 $177K
Rd Expense Q2 2025 · Jun 30, 2024 $1.43M
Rd Expense Q2 2025 · Jun 30, 2024 $2.92M
Net Income Q2 2025 · Jun 30, 2025 −$1.08M
Net Income Q2 2025 · Jun 30, 2025 −$2.67M
Net Income Q2 2025 · Mar 31, 2025 −$1.59M
Net Income Q2 2025 · Jun 30, 2024 −$4.06M
Net Income Q2 2025 · Jun 30, 2024 −$8.45M
Net Income Q2 2025 · Mar 31, 2024 −$4.38M
Operating Income Q2 2025 · Jun 30, 2025 −$1.14M
Operating Income Q2 2025 · Jun 30, 2025 −$3.1M
Operating Income Q2 2025 · Jun 30, 2024 −$4.21M
Operating Income Q2 2025 · Jun 30, 2024 −$8.79M
Stock Issued Q2 2025 · Dec 31, 2024 21.07M sh